Octapharma's office in Brazil: Bloco A, Sala Rio de Janeiro RJ
Business Address: Av. Ator José Wilker nº 605, Bloco 1 A, Sala 1118 22775-024 Rio de Janeiro - RJ
Phone: +3221 2421 1681
Fax: +55 21 2421 1691
Web: https://www.octapharma.com.br/
Type | Private |
---|---|
Industry | Pharmaceutical industry |
Founded | 1983 |
Headquarters | Lachen, Switzerland |
Number of locations | 31 |
Products | octanate; octanine-F; wilate; Nuwiq; octagam; gammanorm; rhesonativ; panzyga; albunorm; octaplas; atenativ; octaplex; octaplasLG; fibryga See complete products listing. |
Revenue | Euro 2.4 billion (2020) |
Number of employees | 9,067(2020) |
Website | www.octapharma.com |
Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do. We are the largest privately owned and independent plasma fractionator in the world. Our medicines are high-quality human proteins sourced from human plasma and human cell lines. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care. Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.